Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (2287)	12/12/2000 3:50:46 PM
From: Biomaven	Read Replies (2) \| Respond to of 52153

tom, Looks like 10:47 today on the FDA site. But I don't know if there's a little back room someplace at the FDA where they let you read it on paper a little earlier. By the way, this release of the FDA documents ahead of the AC meetings is a new phenomenon. By the way, sometimes (but not I think in MAXM's case), you have to take the statistics review with a grain of salt. Usually they are at very least picky, and I don't recall ever seeing one that was actually positive. I guess they are intended as an adversarial document in opposition to the company's own (always favorable) slant. Peter